Drug Interactions in Coronary Heart Disease Patients : a Literature Review
Article Sidebar
Main Article Content
Abstract
Background: Patients with coronary heart disease generally receive many drugs, such as hypercholesterolemia, antianginal, antiplatelet, anticoagulants, and medications for comorbid illnesses such as antihypertension and diabetes mellitus. Concomitant administration of several types of drugs may result in drug interactions.
Objective : This study aims to figure out drug interactions that might occur in using combination drugs in patients with coronary heart disease.
Methods: This article review uses the Google Scholar database, published 2017-2022. The keywords used were "coronary heart disease and drug interactions." The PRISMA flowchart is used to summarize the article selection process.
Results: Administration of aspirin with clopidogrel causes a moderate synergistic interaction, whereas administration of antiplatelet agents with anticoagulants causes a significant synergistic interaction on bleeding. And the administration of nifedipine with atorvastatin causes a synergistic pharmacodynamic interaction.
Conclusions: Drug interactions occur in patients with coronary heart disease, either synergistic or antagonistic pharmacodynamic interactions with minor, moderate, and significant classifications
Downloads
Article Details
Copyright (c) 2023 Elok Tamarah, Handayani Handayani; Andik Ferdiantoro
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Aprilianti RG. dkk. 2022. Gambaran interaksi obat penyakit jantung coroner dengan sindrom metabolic pada pasien rawat jalan di RS TK II DR. Soepraoen Malang. Jurnal riset kefarmasian Indonesia. VOL.4 NO.1. DOI: https://doi.org/10.33759/jrki.v4i1.222
Auliafendri dan Darmiyani. 2022.
Evaluasi interaksi obat jantung koroner pada pasien rawat inap di rumah sakit umum Imelda pekerja Indonesia Medan. Jurnal Ilmiah Farmasi Imelda. Vol.5, No.2.
PERKI., 2016, buku PPK dan CP penyakit jantung dan pembuluh darah, PERKI, Jakarta.
PERKI. 2018. Pedoman Tata Laksana Sindroma Koroner Akut. Edisi Keempat.
Rahmawati DU dan Mutmainah N. 2021. Kajian Interaksi Obat Potensial Pada Pasien
Penyakit Jantung Koroner Rawat Inap di RSUD Moewardi Tahun 2018. Urecol. Sekolah Tinggi Ilmu Kesehatan Muhammadiyah Klaten.
Robiyatul S. dkk. 2021. Kajian interaksi obat aktual pada pasien jantung koroner di Rumah Sakit X Kota Tasikmalaya. Jurnal farmasi Muhammadiyah Kuningan. 6(1): 7-11. DOI: https://doi.org/10.55093/jurnalfarmaku.v6i1.157
Wahidah dan Harahap RA. 2021. PJK (Penyakit Jantung Koroner) dan SKA (Sindrome Koroner Akut) dari Prespektif Epidemiologi. Jurnal Kesehatan Masyarakat, Vol.6, No. 1 Hal. 54-65.